当前位置：
X-MOL 学术
›
J. Child Adolesc. Psychopharmacol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Effects of Antidepressant Treatment on Symptom Measures of Attention in Adolescents with Depression: A Preliminary Open-Label Study
Journal of Child and Adolescent Psychopharmacology ( IF 1.5 ) Pub Date : 2021-05-19 , DOI: 10.1089/cap.2020.0101 Chi-Hyun Choi 1 , Jung Lee 2 , Kyung Hwa Lee 3 , Soon-Beom Hong 3 , Seong-Hae Kim 3 , Ji-Youn Han 3 , Jun Won Kim 4 , Soo Churl Cho 5 , Jae-Won Kim 3
Journal of Child and Adolescent Psychopharmacology ( IF 1.5 ) Pub Date : 2021-05-19 , DOI: 10.1089/cap.2020.0101 Chi-Hyun Choi 1 , Jung Lee 2 , Kyung Hwa Lee 3 , Soon-Beom Hong 3 , Seong-Hae Kim 3 , Ji-Youn Han 3 , Jun Won Kim 4 , Soo Churl Cho 5 , Jae-Won Kim 3
Affiliation
Objective: The effects of selective serotonin reuptake inhibitor (SSRI) on deficits in attention and executive function in adolescents with major depressive disorder (MDD) are relatively unknown. We aimed to investigate changes in symptom measures of attention in adolescents with MDD treated with escitalopram.
中文翻译：
抗抑郁治疗对青少年抑郁症症状症状测量的影响：一项初步的开放标签研究
目的：选择性5-羟色胺再摄取抑制剂（SSRI）对重度抑郁症（MDD）青少年注意力和执行功能缺陷的影响相对未知。我们旨在调查接受依他普仑治疗的 MDD 青少年注意力症状测量的变化。
更新日期：2021-05-22
中文翻译：
抗抑郁治疗对青少年抑郁症症状症状测量的影响：一项初步的开放标签研究
目的：选择性5-羟色胺再摄取抑制剂（SSRI）对重度抑郁症（MDD）青少年注意力和执行功能缺陷的影响相对未知。我们旨在调查接受依他普仑治疗的 MDD 青少年注意力症状测量的变化。
京公网安备 11010802027423号